• Center on Health Equity & Access
  • Clinical
  • Health Care Cost
  • Health Care Delivery
  • Insurance
  • Policy
  • Technology
  • Value-Based Care

Kim Woofter on How Data Will Change Care Delivery in the Next 5 Years

Video

Value-based care will start to transition from being an option to being a requirement, and better data will be needed to improve how care is delivered to patients, said Kim Woofter, executive vice president of strategic alliances and practice innovation at the Advanced Centers for Cancer Care.

Value-based care will start to transition from being an option to being a requirement, and better data will be needed to improve how care is delivered to patients, said Kim Woofter, executive vice president of strategic alliances and practice innovation at the Advanced Centers for Cancer Care.

Transcript (slightly modified)

What changes do you expect to see in the next 5 years in how we use data to deliver care to patients?

The changes I expect to see in the next 5 years is up to this point it was an option if you want to provide value-based care. When I talk about value-based care I’m talking about the continuum, end-of-life management, and NCCN [National Comprehensive Cancer Network] guidelines—actually following a structured path that’s best for the patient and their family. Up to this point again, it’s been an option—it’s something you did because it was the right thing to do.

I think in the future it’s going to be required and it’s not going to be an option. That’s a good thing for the patient, their family, and the healthcare system as a whole, but we’re going to need the data sets and the data analytics, and access to that on all levels—from large practices to very small. It’s going to have to be cost effective or affordable for practices to get their hands on that technology.

That’s what I think is going to be the biggest hurdle coming our way and the biggest change is no longer going to be an option—it’s going to be a requirement.

Related Videos
Surbhi Sidana, MD, MBBS
Mabel Mardones, MD.
Mei Wei, MD.
Screenshot of Susan Wescott, RPh, MBA
Glenn Balasky, executive director of the Rocky Mountain Cancer Center.
Screenshot of an interview with Stuart Staggs
Screenshot of an interview with Adam Colborn, JD
Screenshot of Stephanie Hsia, PharmD
Screenshot of an interview with James Chambers, PhD
Screenshot of an interview with Megan Ehret, PharmD
Related Content
© 2024 MJH Life Sciences
AJMC®
All rights reserved.